查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563125

连续血糖监测系统的全球市场：依产品、应用、最终用户和地区的预测（~2032年）

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product, By Application, By End User, by Region Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 152 Pages | 订单完成后即时交付

价格

预计连续血糖监测系统市场规模将从2023年的88亿美元和2024年的100亿美元成长到2032年的258亿美元，预测期内年复合成长率为 12.34%。

推动连续血糖监测系统市场扩张的显着因素之一是全球糖尿病盛行率的上升。由于全世界受影响人数的显着增加，糖尿病现已达到流行病的程度。The International Diabetes Federation（IDF）表示，2021年全球将有5.37亿人患有糖尿病，预测到2030年这一数字将增加至6.43亿。同样，IDF 估计2021年有3,840万美国人（占总人口的11.6%）患有糖尿病。大约200万美国人患有第1 型糖尿病，其中包括约 304,000名儿童和青少年。糖尿病发生率上升的原因包括人口老化、不良饮食习惯和不活跃的生活方式。随着糖尿病人口的增加，对有效的糖尿病护理解决方案的需求也在增加。

区域洞察

北美市场所占占比最大。预计该市场将受到强大的技术基础设施和完善的监管框架的推动。

由于糖尿病盛行率上升和 CGM 技术的发展，欧洲占据第二大市场。

预计2023年至2032年，亚太地区将以惊人的速度成长。这是由于该地区糖尿病盛行率不断上升以及糖尿病管理意识不断增强的结果。

本报告调查了全球连续血糖监测系统市场，提供市场的定义和概述，市场成长的各种影响因素分析，市场规模推移和预测，各种区分、地区的细分，竞争环境，主要企业概况等彙整资料。

目录

第1章 执行摘要

第2章 市场概述

第3章 研究方法

第4章 市场动态

  • 促进因素
    • 糖尿病盛行率不断上升
    • 提高个人对连续血糖监测系统和病患教育益处的认识
    • 人口老化加剧
  • 抑制因素
    • 连续血糖监测系统成本高
  • 机会
    • 科技与创新的进步

第5章 市场因素分析

  • 价值链分析
  • 波特五力分析
  • COVID-19 对全球连续血糖监测系统市场的影响

第6章 全球连续血糖监测系统市场：依产品

  • 摘要
  • 感测器
  • 发射器/接收器

第7章 全球连续血糖监测系统市场：依应用分类

  • 摘要
  • 2 型糖尿病
  • 1 型糖尿病
  • 非糖尿病患者
    • 体重减轻
    • 饮食管理
    • 健康/保健

第8章 全球连续血糖监测系统市场：依最终用户

  • 摘要
  • 医院/诊所
  • 居家护理
  • 其他

第9章 依地区的全球连续血糖监测系统市场

  • 世界
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第10章 竞争态势

  • 市占率分析
  • 竞争仪表板
  • 上市公司股票概览
  • 比较分析：主要公司的财务趋势
  • 主要发展与成长策略

第11章 公司简介

  • DEXCOM, INC
  • A. MENARINI DIAGNOSTICS SRL
  • SENSEONICS
  • MEDTRUM TECHNOLOGIES INC.
  • NEMAURA MEDICAL INC.
  • ULTRAHUMAN HEALTHCARE PVT LTD
  • MEDTRONIC
  • ONE DROP
  • ABBOTT LABORATORIES, INC.
  • SINOCARE
  • NUTRISENSE
  • SUPERSAPIENS
  • SIGNOS INC.
  • LEVELS
  • VERI
  • LUMEN
  • JANUARY.AI

第12章 资料引用

Product Code: MRFR/HC/18762-CR

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Outlook

USD 8.8 billion in continuous glucose monitoring systems market value in 2023 With a compound annual growth rate (CAGR) of 12.34% for the forecast period (2024 - 2032), the market for Continuous Glucose Monitoring Systems is expected to rise from USD 10.0 Billion in 2024 to USD 25.8 billion by 2032.

One very notable factor driving the expansion of the Continuous Glucose Monitoring Systems Market is the rising global diabetes prevalence. With an amazing global increase in affected individuals, diabetes now reaches pandemic proportions. The International Diabetes Federation (IDF) estimates that 537 million people globally will be living with diabetes in 2021 and that figure is predicted to rise to 643 million by 2030. Likewise, the American Diabetes Association estimates that in 2021 diabetes will afflict 38.4 million Americans, or 11.6% of the population. About 2.0 million Americans, including some 304,000 children and teenagers, have type 1 diabetes. Among the several causes of the rising diabetes incidence include aging population, poor eating habits, and inactive lifestyles. The need of efficient diabetes care solutions gets more urgent as the diabetic population keeps rising.

Insights about Market Segments

Based on product, the segmentation of the Continuous Glucose Monitoring Systems Market divides sensors and transmitter and receivers.

Application that comprises type 2 diabetes, type 1 diabetes, and non-diabetic patients forms the basis of the market segmentation.

End users ranging from hospitals and clinics to homecare environments and others form the basis of the market segmentation.

Regional Insights

The report groups the market by Region: North America, Europe, Asia-Pacific, and the Rest of the World. America North-West With a market share of the highest 2023 constant glucose monitoring systems The strong technological infrastructure is the reason behind this; so, it is envisaged that the market would be driven by a well-established regulatory framework.

Thanks to rising diabetes prevalence in Europe and developments in CGM technology, Europe Continuous Glucose Monitoring Systems market holds second-largest market share. Furthermore, the Rest of Europe Continuous Glucose Monitoring Systems market is predicted to fastest-growing market in the European area while France Continuous Glucose Monitoring Systems market was ascribed to hold the highest market share.

From 2023 to 2032, the Asia-Pacific Continuous Glucose Monitoring Systems market is predicted to expand at a noteworthy proportion. This is a result of growing diabetes prevalence in the area and growing consciousness of diabetes control. Furthermore projected to have the biggest market share is China Continuous Glucose Monitoring Systems market; India Market for Continuous Glucose Monitoring Systems is predicted to develop fastest among Asia-Pacific countries.

The Middle East and Africa plus Latin America comprise the Rest of the World. Rising diabetes prevalence along with growing awareness of advanced glucose monitoring systems would probably cause the market for Continuous Glucose Monitoring Systems in the above stated areas to rise.

Leading Players

Key Companies in the Continuous Glucose Monitoring Systems Market are Dexcom, Inc. (US), Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt LTD (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), Sinocare (China).

TABLE OF CONTENTS

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF DIABETES
    • 4.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
    • 4.2.3 INCREASING GERIATRIC POPULATION
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
    • 5.3.1 OVERVIEW

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 SENSORS
  • 6.3 TRANSMITTER & RECEIVERS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 TYPE 2 DIABETES
  • 7.3 TYPE 1 DIABETES
  • 7.4 NON-DIABETIC PATIENTS
    • 7.4.1 WEIGHT LOSS
    • 7.4.2 DIET MANAGEMENT
    • 7.4.3 HEALTH & WELLNESS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS & CLINICS
  • 8.3 HOMECARE SETTINGS
  • 8.4 OTHERS

9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

  • 9.1 GLOBAL
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST & AFRICA
    • 9.5.2 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS,
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
    • 10.6.2 AGREEMENT
    • 10.6.3 PARTNERSHIP
    • 10.6.4 COLLABORATION

11 COMPANY PROFILES

  • 11.1 DEXCOM, INC
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 A. MENARINI DIAGNOSTICS SRL
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 KEY STRATEGIES
  • 11.3 SENSEONICS
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 MEDTRUM TECHNOLOGIES INC.
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 NEMAURA MEDICAL INC.
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 ULTRAHUMAN HEALTHCARE PVT LTD
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 MEDTRONIC
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 ONE DROP
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 ABBOTT LABORATORIES, INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 SINOCARE
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES
  • 11.11 NUTRISENSE
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCTS OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 KEY STRATEGIES
  • 11.12 SUPERSAPIENS
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCTS OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 KEY STRATEGIES
  • 11.13 SIGNOS INC.
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 FINANCIAL OVERVIEW
    • 11.13.3 PRODUCTS OFFERED
    • 11.13.4 KEY DEVELOPMENTS
    • 11.13.5 KEY STRATEGIES
  • 11.14 LEVELS
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 FINANCIAL OVERVIEW
    • 11.14.3 PRODUCTS OFFERED
    • 11.14.4 KEY DEVELOPMENTS
    • 11.14.5 KEY STRATEGIES
  • 11.15 VERI
    • 11.15.1 COMPANY OVERVIEW
    • 11.15.2 FINANCIAL OVERVIEW
    • 11.15.3 PRODUCTS OFFERED
    • 11.15.4 KEY DEVELOPMENTS
    • 11.15.5 KEY STRATEGIES
  • 11.16 LUMEN
    • 11.16.1 COMPANY OVERVIEW
    • 11.16.2 FINANCIAL OVERVIEW
    • 11.16.3 PRODUCTS OFFERED
    • 11.16.4 KEY DEVELOPMENTS
    • 11.16.5 KEY STRATEGIES
  • 11.17 JANUARY.AI
    • 11.17.1 COMPANY OVERVIEW
    • 11.17.2 FINANCIAL OVERVIEW
    • 11.17.3 PRODUCTS OFFERED
    • 11.17.4 KEY DEVELOPMENTS
    • 11.17.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 26 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 30 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 35 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 39 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 47 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 51 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 55 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 59 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 64 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 68 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 72 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 76 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 80 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 84 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 88 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 89 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 93 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 97 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 101 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 102 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 103 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 104 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 105 AGREEMENT
  • TABLE 106 PERTNERSHIP
  • TABLE 107 COLLABORATION
  • TABLE 108 DEXCOM, INC: PRODUCT OFFERED
  • TABLE 109 DEXCOM, INC: KEY DEVELOPMENTS
  • TABLE 110 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
  • TABLE 111 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
  • TABLE 112 SENSEONICS: PRODUCT OFFERED
  • TABLE 113 SENSEONICS: KEY DEVELOPMENTS
  • TABLE 114 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
  • TABLE 115 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 116 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
  • TABLE 117 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
  • TABLE 118 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 119 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 120 ONE DROP: PRODUCTS OFFERED
  • TABLE 121 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 122 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
  • TABLE 123 SINOCARE: PRODUCTS OFFERED
  • TABLE 124 NUTRISENSE: PRODUCTS OFFERED
  • TABLE 125 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 126 SIGNOS INC.: PRODUCTS OFFERED
  • TABLE 127 LEVELS: PRODUCTS OFFERED
  • TABLE 128 VERI: PRODUCTS OFFERED
  • TABLE 129 LUMEN: PRODUCTS OFFERED
  • TABLE 130 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT,
  • FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION,
  • FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER,
  • FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION,
  • FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS,
  • FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
  • FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
  • FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 32 ONE DROP: SWOT ANALYSIS
  • FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS LIST OF FIGURES
  • FIGURE 1 GLOBAL DIGITAL HEALTH MARKET: STRUCTURE
  • FIGURE 2 GLOBAL DIGITAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL DIGITAL HEALTH MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DIGITAL HEALTH MARKET
  • FIGURE 7 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
  • FIGURE 8 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
  • FIGURE 9 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY TECHNOLOGY,
  • FIGURE 10 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
  • FIGURE 11 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)
  • FIGURE 12 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY COMPONENT,
  • FIGURE 13 GLOBAL DIGITAL HEALTH MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL DIGITAL HEALTH MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
  • FIGURE 15 GLOBAL DIGITAL HEALTH MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY END USER,
  • FIGURE 17 GLOBAL DIGITAL HEALTH MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 18 GLOBAL DIGITAL HEALTH MARKET, BY REGION, 2023 AND 2032 (USD MILLION)
  • FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
  • FIGURE 20 NORTH AMERICA: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 21 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 & 20232 (USD MILLION)
  • FIGURE 22 EUROPE MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
  • FIGURE 23 EUROPE: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 24 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
  • FIGURE 25 ASIA-PAIFIC MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
  • FIGURE 26 ASIA-PAIFIC: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 27 ASIA-PAIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
  • FIGURE 28 REST OF THE WORLD MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
  • FIGURE 29 REST OF THE WORLD: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 30 REST OF THE WORLD: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
  • FIGURE 31 GLOBAL DIGITAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS,
  • FIGURE 32 COMPETITOR DASHBOARD: GLOBAL DIGITAL HEALTH MARKET
  • FIGURE 33 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 ATHENAHEALTH: SWOT ANALYSIS
  • FIGURE 35 CISCO SYSTEMS, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS
  • FIGURE 37 NXGN MANAGEMENT, LLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 NXGN MANAGEMENT, LLC: SWOT ANALYSIS
  • FIGURE 39 MCKESSON CORPORATION: FINANCIAL OVERVIEW
  • FIGURE 40 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
  • FIGURE 41 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW
  • FIGURE 42 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
  • FIGURE 43 VERADIGM, LLC: FINANCIAL OVERVIEW SNAPSHOT